Skip to main content

Table 2 Results of the association between CTSD C224T polymorphism and AD risk in the meta-analysis

From: Lack of association between cathepsin D C224T polymorphism and Alzheimer’s disease risk: an update meta-analysis

Comparison

Population

No. of studies

Test of association

Mode

Test of heterogeneity

   

OR

95% CI

P Value

 

x 2

PQValue

I2

 CT vs. CC

Overall

25

1.125

0.974–1.299

0.109

R

39.65

0.023

39.5

 CT + TT vs. CC

Overall

25

1.136

0.978–1.320

0.094

R

44.23

0.007

45.7

Subgroup analysis

Ethnicity

         

 CT vs. CC

Asian

4

0.971

0.626–1.506

0.895

F

2.04

0.565

0.0

 

Caucasian

21

1.139

0.974–1.331

0.102

R

37.20

0.011

46.2

 CT + TT vs. CC

Asian

4

0.954

0.616–1.477

0.833

F

2.04

0.565

0.0

 

Caucasian

21

1.154

0.982–1.357

0.082

R

41.54

0.003

51.8

EOAD

         

 CT vs. CC

Overall

6

0.937

0.706–1.245

0.654

F

2.87

0.719

0.0

 CT + TT vs. CC

Overall

6

0.93

0.704–1.229

0.612

F

2.68

0.749

0.0

LOAD

         

 CT vs. CC

Overall

6

0.935

0.724–1.207

0.606

F

3.86

0.57

0.0

 CT + TT vs. CC

Overall

6

0.931

0.726–1.195

0.575

F

3.88

0.567

0.0

  1. OR, odds ratio; CI, confidence intervals; R, random effects model; F, fixed effects model; EOAD, early-onset AD; LOAD ,late-onset AD.